These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 26936767)

  • 1. Motif mediated protein-protein interactions as drug targets.
    Corbi-Verge C; Kim PM
    Cell Commun Signal; 2016 Mar; 14():8. PubMed ID: 26936767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational modulator design by exploitation of protein-protein complex structures.
    Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
    Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.
    Arkin MR; Tang Y; Wells JA
    Chem Biol; 2014 Sep; 21(9):1102-14. PubMed ID: 25237857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-protein interactions as drug targets.
    Skwarczynska M; Ottmann C
    Future Med Chem; 2015; 7(16):2195-219. PubMed ID: 26510391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of RNA-targeting macrocyclic peptides.
    Walker MJ; Varani G
    Methods Enzymol; 2019; 623():339-372. PubMed ID: 31239053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational Design of PDZ Domain Inhibitors: Discovery of Small Organic Compounds Targeting PDZ Domains.
    Hoffer L; Roche P; Morelli X
    Methods Mol Biol; 2021; 2256():277-289. PubMed ID: 34014528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and screening of small-molecule α-helix mimetic libraries targeting protein-protein interactions.
    Moon H; Lim HS
    Curr Opin Chem Biol; 2015 Feb; 24():38-47. PubMed ID: 25461722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
    Shin WH; Christoffer CW; Kihara D
    Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.
    Ran X; Gestwicki JE
    Curr Opin Chem Biol; 2018 Jun; 44():75-86. PubMed ID: 29908451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of an Irreversible and Cell-Active BCL6 Inhibitor Selectively Targeting Cys53 Located at the Protein-Protein Interaction Interface.
    Sameshima T; Yamamoto T; Sano O; Sogabe S; Igaki S; Sakamoto K; Ida K; Gotou M; Imaeda Y; Sakamoto J; Miyahisa I
    Biochemistry; 2018 Feb; 57(8):1369-1379. PubMed ID: 29293322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of inhibitors of Bcl-2 family protein-protein interaction by combining the BRET screening platform with virtual screening.
    Park IS; Seo HR; Kim K; Lee H; Shum D; Choi I; Kim J
    Biochem Biophys Res Commun; 2020 Jun; 527(3):709-715. PubMed ID: 32423828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidomimetics Targeting Protein-Protein Interactions for Therapeutic Development.
    Zhang G; Andersen J; Gerona-Navarro G
    Protein Pept Lett; 2018; 25(12):1076-1089. PubMed ID: 30381055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-encoded chemical libraries of macrocycles.
    Connors WH; Hale SP; Terrett NK
    Curr Opin Chem Biol; 2015 Jun; 26():42-7. PubMed ID: 25710630
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of Amino Acid Mutations and Small Molecules on Targeted Inhibition of Proteins Involved in Cancer.
    Kanakaveti V; Anoosha P; Sakthivel R; Rayala SK; Gromiha MM
    Curr Top Med Chem; 2019; 19(6):457-466. PubMed ID: 30836917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential for caspases in drug discovery.
    MacKenzie SH; Schipper JL; Clark AC
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):568-76. PubMed ID: 20812148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design of high-affinity macrocyclic peptidomimetics to block the menin-mixed lineage leukemia 1 (MLL1) protein-protein interaction.
    Zhou H; Liu L; Huang J; Bernard D; Karatas H; Navarro A; Lei M; Wang S
    J Med Chem; 2013 Feb; 56(3):1113-23. PubMed ID: 23244744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.
    Scott DE; Bayly AR; Abell C; Skidmore J
    Nat Rev Drug Discov; 2016 Aug; 15(8):533-50. PubMed ID: 27050677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of Rigidity in Designing Small Molecule Drugs To Tackle Protein-Protein Interactions (PPIs) through Stabilization of Desired Conformers.
    Lawson ADG; MacCoss M; Heer JP
    J Med Chem; 2018 May; 61(10):4283-4289. PubMed ID: 29140691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Stapled Peptides and Small Molecules to Inhibit Protein-Protein Interactions in Cancer.
    Iyer VV
    Curr Med Chem; 2016; 23(27):3025-3043. PubMed ID: 27356541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MultiBacMam Bimolecular Fluorescence Complementation (BiFC) tool-kit identifies new small-molecule inhibitors of the CDK5-p25 protein-protein interaction (PPI).
    Bellón-Echeverría I; Carralot JP; Del Rosario AA; Kueng S; Mauser H; Schmid G; Thoma R; Berger I
    Sci Rep; 2018 Mar; 8(1):5083. PubMed ID: 29572554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.